节点文献

肿瘤相关性高内皮微静脉在肿瘤治疗中角色的研究进展

Research progress on the role of tumor-associated high endothelial venules in anti-tumor therapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘妍张传桂

【Author】 Yan Liu;Chuangui Zhang;Department of VIP Ward, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer;

【通讯作者】 张传桂;

【机构】 天津医科大学肿瘤医院特需病房,国家恶性肿瘤临床医学研究中心,天津市“肿瘤防治“重点实验室,天津市恶性肿瘤临床医学研究中心

【摘要】 在恶性肿瘤中发现的表型类似于次级淋巴器官(secondary lymphoid organ, SLO)中高内皮微静脉(high endothelial venules,HEVs)的血管被称为肿瘤相关性高内皮微静脉(tumor-associated high endothelial venules,TA-HEVs),其在肿瘤中的形成与次级淋巴器官中HEVs的形成机制相似。TA-HEVs在促使淋巴细胞浸润肿瘤组织的过程中发挥了重要作用。随着对TAHEVs研究深入,其在放疗、化疗、免疫治疗及抗血管生成治疗等抗肿瘤治疗中发挥积极作用,TA-HEVs的临床价值逐步凸显,本文将对其相应的机制、通路等进行综述。

【Abstract】 Malignant tumor blood vessels, with phenotypes that are similar to high endothelial venules(HEVs) in secondary lymphoid organs(SLO), are known as tumor-associated high endothelial venules(TA-HEVs). The formation mechanism of TA-HEVs is similar to that of HEVs. Moreover, TA-HEVs play an important role in promoting the infiltration of lymphocytes into tumor tissues. With ongoing research, the positive effect of TA-HEVs in the context of radiotherapy, chemotherapy, immunotherapy, and antiangiogenic therapy is being elucidated.The clinical value is gradually becoming prominent, and the mechanisms and pathways involved with TA-HEVs are still under investigation.

【基金】 天津市医学重点学科(专科)建设项目(编号:TJYXZDXK 009A)资助~~
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2023年23期
  • 【分类号】R730.5
  • 【下载频次】16
节点文献中: 

本文链接的文献网络图示:

本文的引文网络